Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06266104

Image Enhanced Endoscopy IBD

Image Enhanced Endoscopy Technology to Improve the Detection of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
270 (estimated)
Sponsor
Royal Perth Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Dye- spray chromoendoscopy remains the recommended gold standard approach for IBD dysplasia surveillance colonoscopy however recently published European and American guidelines recommend either dye-spray or virtual chromoendoscopy can be used for surveillance. The newer Imaged Enhanced Endoscopy technologies TXI and LCI have not formally been evaluated in IBD surveillance in a randomised controlled trial setting. These modes can easily be applied during colonoscopy and if demonstrated to be effective may save time and eliminate the need for dye-spray chromoendoscopy in the future.

Conditions

Interventions

TypeNameDescription
PROCEDUREImage Enhanced Endoscopy FiltersPatients that undergoing surveillance and consent to be involved in the study will be randomised to undergo surveillance with LCI, TXI or dye-spray chromoendoscopy (methylene blue).

Timeline

Start date
2024-04-03
Primary completion
2025-12-31
Completion
2026-03-01
First posted
2024-02-20
Last updated
2024-04-12

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT06266104. Inclusion in this directory is not an endorsement.